IBEX Limited (IBEX) key performance indicators and operating metrics (10 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Free Cash Flow | 6.6M | FY2026-Q3 |
| Total Revenue Growth Year Over Year | 16.80 percent | FY2026-Q3 |
| Adjusted Fully Diluted Earnings Per Share | 0.91 USD_per_share | FY2026-Q3 |
| Non-GAAP Adjusted EBITDA Margin | 13.40 percent | FY2026-Q3 |
| Adjusted Net Income | 13.6M | FY2026-Q3 |
| Non-GAAP Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization | 22M | FY2026-Q3 |
| HealthTech Revenue Growth Rate | 53.70 percent | FY2026-Q3 |
| Retail and E-Commerce Revenue Growth Rate | 8.30 percent | FY2026-Q3 |
| Travel, Transportation and Logistics Revenue Growth Rate | 15.10 percent | FY2026-Q3 |
| Non-GAAP Adjusted EBITDA | 20.7M | FY2026-Q2 |
Back to IBEX overview · IBEX earnings · IBEX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.